Member Info for Pingu777

Partnered up with PENN to rush through these IND enabling studies imo. We will receive many levels of professional expertise From PENN but the key to expedited timescales will be the bigger resource and capacity to complete multiple lines of testing simulataneously.

I agree LondonTrader

He’s just taking some profits from where eve got in. Prob sold down from 10s to 8.3, got 9pish. From getting in in the 5s or less that’s decent profit.

If it is a transfer then why has the SP dipped so much? Background seller makes sense of it.

Mr Johnson selling means nothing to me in terms of DEV. I’ll try find out the share splits and see what he has left.

I knew Bob Johnson was a trading pumper on Akers coat tails. Couldn’t wait to sell when he’d made a few quid. Explains the SP dip as he’s sold a chunk.

What’s your average FSA? Are you leveraged? No other reason for any concern here. DEV got all the pieces in place now to move to the next level. a number of high quality TR1s. North America roll out results soon enough and then we go global!

What an excellent buy in/top up opp Imo.

Is an embarrassing clueless investor. Makes me sad that losers like you are sniffing about my HEMO. Tell me some facts about HEMO And it’s amazingness. Xxxx

Pumpky so sometimes you’re in, sometimes you’re out.

And where you’re out you’re a tool on this chat. Disrupt etc etc

You couldn’t tell me anything about your cross ramp or Hemo. You probably couldnt even tell me their asset portfolio that’s potentially commercial?

Totally agree mate. Literally offers nothing. Even when mentions other shares can’t tell me a single thing about them. Worst researcher ever. Invests with a guess. Good luck.

Pumpky, what are your views on the broader application of CDX to other auto-immune diseases than AML/ALL? With a the right blend of NK cells do you think they’re working on an adapted version for lupus and/or possibly Covid?

Also, do you have any views on the impact of the Penn development deal for HEMO CAR T? What AML patients will it target? In what way is it different from CDX in its application and effectiveness?

2 x 200,000 share sells this aft. Wonder who’s flogged those?
Doesn’t worry me! Absorbed above support!

One question. What happens with the SPs on the de-merger? STEMprint valued at £1.50 a share apparently in the new company. What happens to the TILs SP? Combined market cap expected to suddenly go up by £300m?

Couldn’t they all get deals pumpky? Arent they all working on different drugs? Why are we comparing HEMO to them?

I’d still like to hear more about SCLP and what they’re working on? Do they have a similar profile to HEMO?

Tell me more about scannell pumper. What are they working on and who’s been kept alive for five years? Xx

Ok hun. Why are you invested in a junior biotech if you don’t think it’ll hit a pound? They’re not 5% a year managed funds.

A lot of good stuff gets posted on here by knowledgable posters. It just gets ruined and glossed over by drivel from other types of poster like you pumper. Be nice if you could contribute something useful for us. I’m sure everyone would be pleased to hear your insight. The floor is yours.

Reasonable numbers once you get to clinical trials.

Phase 1 to 2 biomarker Clinical trial success rate.
- Oncology, Non bio marker 28%, bio marker 43.5%
- Autoimmune non 38.9% v bio 55.6%
- Infectious diseases 39.7% v 66.7%

Phase 2 to 3
- oncology non 17.4% v bio 38.8%
- Autoimmune 25.4% v 35.7%
- Infectious diseases 34.7% v 44.4%

A lot of the recorded drug failures happen pre-clinical.

In 12 months from now I’ll be frustrated if it’s the £1. I expect a takeover in 2021 by ELI.

An it it’s nearer a billion the we’re £2+

Also CAR T to human trials self-funded says kerching

The company is big time. Those who haven’t researched enough I feel sorry for you. I’m a bit obsessive about hemo, but it’s only because they re so big time. Please read up on what HEMO do and how it is novel and best in class. Invest, sit back and Collect in a year. So easy.

Anyone got any doubts about HEMOs astronomical rise to stardom?

VST not updated for months? Plenty of market share for CTEA. Deals don’t just appear after a week of work. They take time. Whether or not they deliver, people need to accept these timescales are normal and there’s nothing wrong yet.

I have emailed the CEO though and he’s not replied which posses me off as an investor. We will see!

Thanks for the observations scotty.

CTEA is tiny. Did you really expect “Scotland” or “Ireland” to adopt it?!?! MacDonalds etc?!?! You’re dreaming. Jeez, they’ll only need a portfolio of defent-sized employers to make dosh. The hospitality sector will be sniffing for sure. And what about all the consortiums contacts in the City? The current practices for track and trace are laughable.

It’s a simple app but it has its place. We shall see soon either way but that’s write it off because it’s not been adopted by Global monster companies or whole nations is laughable.